NO986087L - Oralt preparat omfattende en antifungal triazolforbindelse - Google Patents

Oralt preparat omfattende en antifungal triazolforbindelse

Info

Publication number
NO986087L
NO986087L NO986087A NO986087A NO986087L NO 986087 L NO986087 L NO 986087L NO 986087 A NO986087 A NO 986087A NO 986087 A NO986087 A NO 986087A NO 986087 L NO986087 L NO 986087L
Authority
NO
Norway
Prior art keywords
beads
oral preparation
triazole compound
antifungal
triazol
Prior art date
Application number
NO986087A
Other languages
English (en)
Norwegian (no)
Other versions
NO986087D0 (no
Inventor
Surendra A Sangekar
Winston A Vadino
Ping I Lee
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO986087D0 publication Critical patent/NO986087D0/no
Publication of NO986087L publication Critical patent/NO986087L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO986087A 1996-06-28 1998-12-23 Oralt preparat omfattende en antifungal triazolforbindelse NO986087L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67243296A 1996-06-28 1996-06-28
PCT/US1997/010122 WO1998000116A1 (en) 1996-06-28 1997-06-25 Oral composition comprising a triazole antifungal compound

Publications (2)

Publication Number Publication Date
NO986087D0 NO986087D0 (no) 1998-12-23
NO986087L true NO986087L (no) 1999-02-26

Family

ID=24698529

Family Applications (1)

Application Number Title Priority Date Filing Date
NO986087A NO986087L (no) 1996-06-28 1998-12-23 Oralt preparat omfattende en antifungal triazolforbindelse

Country Status (16)

Country Link
EP (1) EP0914100A1 (cs)
JP (1) JP2000514059A (cs)
KR (1) KR20000022294A (cs)
CN (1) CN1228693A (cs)
AU (1) AU731704B2 (cs)
BR (1) BR9710069A (cs)
CA (1) CA2258683C (cs)
CZ (1) CZ421498A3 (cs)
HU (1) HUP9903869A3 (cs)
IL (1) IL127780A0 (cs)
NO (1) NO986087L (cs)
NZ (1) NZ333514A (cs)
PL (1) PL330864A1 (cs)
SK (1) SK177598A3 (cs)
TR (1) TR199802718T2 (cs)
WO (1) WO1998000116A1 (cs)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3608800B2 (ja) * 1997-03-26 2005-01-12 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 抗真菌剤およびポリマーでコートされたコアを有するペレット剤
DE1003485T1 (de) * 1998-06-11 2000-11-02 Em Industries, Inc. Mikroosmotisches gesteuertes arzneistoffabgabesysteme
WO2000003697A1 (en) * 1998-07-17 2000-01-27 Janssen Pharmaceutica N.V. Pellets having a core coated with an antifungal and a polymer
ES2157731B1 (es) * 1998-07-21 2002-05-01 Liconsa Liberacion Controlada Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion.
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
FR2795961B1 (fr) * 1999-07-09 2004-05-28 Ethypharm Lab Prod Ethiques Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation
US7863331B2 (en) 1999-07-09 2011-01-04 Ethypharm Pharmaceutical composition containing fenofibrate and method for the preparation thereof
KR100694667B1 (ko) * 1999-12-08 2007-03-14 동아제약주식회사 생체내이용률 향상과 개인간 및 개인내 흡수 편차를감소시킨 이트라코나졸 함유 항진균성 제제
EP1842532A3 (en) * 2001-02-06 2009-04-22 Stiefel Laboratories, Inc. Oral sparingly water-soluble antifungal formulations and methods of making the same
US6663897B2 (en) * 2001-02-06 2003-12-16 Dsm Ip Assets B.V. Oral itraconazole formulations and methods of making the same
FR2842736B1 (fr) 2002-07-26 2005-07-22 Flamel Tech Sa Formulation pharmaceutique orale sous forme d'une pluralite de microcapsules permettant la liberation prolongee de principe(s) actif(s) peu soluble(s)
ITMI20031096A1 (it) * 2003-05-30 2004-11-30 Eurand Spa Microcapsule per coacervazione contenenti farmaco incorporato nel polimero di rivestimento
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
WO2016205423A2 (en) 2015-06-15 2016-12-22 Lipocine Inc. Composition and method for oral delivery of androgen prodrugs
CN105949278B (zh) * 2016-03-30 2019-12-06 南京曼杰生物科技有限公司 一种取代的四氢呋喃水溶性衍生物及其应用
WO2018098501A1 (en) 2016-11-28 2018-05-31 Lipocine Inc. Oral testosterone undecanoate therapy
WO2020018974A1 (en) 2018-07-20 2020-01-23 Lipocine Inc. Liver disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580578A (en) * 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
PH30929A (en) * 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
JP2834889B2 (ja) * 1993-12-21 1998-12-14 シェーリング コーポレイション テトラヒドロフラン抗真菌剤

Also Published As

Publication number Publication date
CA2258683C (en) 2007-07-31
NZ333514A (en) 2000-05-26
AU731704B2 (en) 2001-04-05
WO1998000116A1 (en) 1998-01-08
CZ421498A3 (cs) 1999-06-16
CA2258683A1 (en) 1998-01-08
TR199802718T2 (xx) 1999-03-22
JP2000514059A (ja) 2000-10-24
NO986087D0 (no) 1998-12-23
HUP9903869A3 (en) 2000-07-28
CN1228693A (zh) 1999-09-15
IL127780A0 (en) 1999-10-28
SK177598A3 (en) 1999-07-12
BR9710069A (pt) 1999-08-10
KR20000022294A (ko) 2000-04-25
EP0914100A1 (en) 1999-05-12
PL330864A1 (en) 1999-06-07
HUP9903869A2 (hu) 2000-06-28
AU3387497A (en) 1998-01-21

Similar Documents

Publication Publication Date Title
NO986087L (no) Oralt preparat omfattende en antifungal triazolforbindelse
CO4970829A1 (es) Polimorfo antifungico cristalino
RU2213731C2 (ru) Производные пиперидина и фармацевтическая композиция на их основе
AR032279A1 (es) Metodo para inhibir una o mas actividades de quinasa proteinica, compuesto de 2 - pirazolin-5-ona inhibidor de quinasa proteinica y composicion farmaceutica que lo comprende
KR920006323A (ko) 아자사이클릭 화합물
JP2001519346A5 (cs)
ES8505364A1 (es) Un procedimiento para la preparacion 1-imidazoles y 1h-1, 2, 4-triazoles
KR900003157A (ko) 트리아졸 항진균제
CZ195696A3 (en) Azoles, process of their preparation and pharmaceutical compositions based thereon
DE3684431D1 (de) Derivate des ((4-(4-(4-phenyl-1-piperazinyl)phenoxymethyl)-1,3-dioxolan-2yl)methyl)-1h-imidazol und 1h-1,2,4-triazol.
JP2002521400A5 (cs)
TR200002097A2 (tr) Triazol ve imidazol türevleri
IT7949830A0 (it) 1-(2-aril-4,5-bisostituiti)-1,3-diossolan-2-il-metil)-1h-imida zoli ed 1h-1,2,4-triazoli dotati di attivita' antimicrobica ed antifunghi e procedimento per la loro preparazione
NZ332699A (en) Antifungal composition with enhanced bioavailability
ES2223893T3 (es) Combinaciones de productos activos fungicidas.
RO94053B (ro) Compozitie fungicida sinergetica
RU97115290A (ru) Соединения азола, способ получения указанных соединений и их применение
RU97116580A (ru) Триазоловое соединение и его фармакологически приемлемая соль и противогрибковая композиция
ATE223404T1 (de) Monoargininylsalz der (e)-3-(1-n-butyl-5-((2-(2- carboxyphenyl)methoxy-4-chlorphenyl)-1h-pyrazol 4-yl)-2-((5-methoxy-2,3-dihydrobenzofuran-6- yl)methyl)-prop-2-en carbonsäure
DE60205239D1 (de) Azol- oder triazol-derivate, verfahren zu deren herstellung und ihre verwendung als antifungale arzneimittel
BRPI0610423B8 (pt) sal de mono-lisina de di-hidrogênio fosfato de ((2r, 3r)-3-(4-(4-cianofenil)-tiazol-2-il)-2-(2,4-difluorofenil)-1-(1h-1,2,4-triazol-1-il)butan-2-iloxi)metila, solvatos do mesmo, composição farma-cêutica compreendendo os mesmos, uso do dito sal para tratar infecções fúngicas e processos para preparar ditos sal e sol- vato
DE60209708D1 (de) Azol- oder triazol-derivate, verfahren zu deren herstellung und ihre verwendung als fungizide
HUP9802763A2 (hu) Fitomikrobicid készítmények és alkalmazásuk
ATE17478T1 (de) 3-substituierte 1-azolyl-3-methyl-1-phenoxy-butan-2-one und -ole, verfahren zu ihrer herstellung und ihre verwendung als fungizide.
ECSP972133A (es) Composiciones antihongos con biodisponibilidad mejorada

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application